Glaukos Corporation (NYSE: GKOS) on Tuesday, plunged -3.00% from the previous trading day, before settling in for the closing price of $124.24. Within the past 52 weeks, GKOS’s price has moved between $83.90 and $163.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 14.35%. The company achieved an average annual earnings per share of 46.86%. With a float of $53.20 million, this company’s outstanding shares have now reached $56.44 million.
Let’s determine the extent of company efficiency that accounts for 995 employees. In terms of profitability, gross margin is 76.61%, operating margin of -32.77%, and the pretax margin is -41.24%.
Glaukos Corporation (GKOS) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Glaukos Corporation is 3.51%, while institutional ownership is 103.77%. The most recent insider transaction that took place on Feb 14 ’25, was worth 502,630. In this transaction CHIEF DEVELOPMENT OFFICER of this company sold 3,416 shares at a rate of $147.14, taking the stock ownership to the 72,437 shares. Before that another transaction happened on Feb 14 ’25, when Company’s Officer proposed sale 3,416 for $147.14, making the entire transaction worth $502,630.
Glaukos Corporation (GKOS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.86% per share during the next fiscal year.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
Glaukos Corporation (GKOS) is currently performing well based on its current performance indicators. A quick ratio of 5.22 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.81, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Looking closely at Glaukos Corporation (NYSE: GKOS), its last 5-days average volume was 1.99 million, which is a jump from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 4.11%. Additionally, its Average True Range was 7.18.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 9.06%, which indicates a significant decrease from 9.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.93% in the past 14 days, which was higher than the 50.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $150.64, while its 200-day Moving Average is $131.40. However, in the short run, Glaukos Corporation’s stock first resistance to watch stands at $125.14. Second resistance stands at $129.77. The third major resistance level sits at $134.23. If the price goes on to break the first support level at $116.04, it is likely to go to the next support level at $111.58. Should the price break the second support level, the third support level stands at $106.95.
Glaukos Corporation (NYSE: GKOS) Key Stats
Market capitalization of the company is 6.64 billion based on 55,137K outstanding shares. Right now, sales total 383,480 K and income totals -146,370 K. The company made 105,500 K in profit during its latest quarter, and -33,580 K in sales during its previous quarter.
